PTC Therapeutics, Inc.
Symbol: PTCT (NASDAQ)
59.68
▲ (2.31%) 1.350
Company Description:
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
Key Stats
- Today's Open: $58.9
- Today's High: $59.799
- Today's Low: $56.2
- Today's Volume: 92.53K
- Yesterday Close: $58.33
- Yesterday High: $59
- Yesterday Low: $57.635
- Yesterday Volume: 917.30K
- Last Min Volume: 1.84K
- Last Min High: $59.683
- Last Min Low: $59.67
- Last Min VWAP: $59.67106
Company Profile
- Name: PTC Therapeutics, Inc.
- Website: https://www.ptcbio.com
- Listed Date: 2013-06-20
- Location: WARREN, NJ
- Market Status: Active
- CIK Number: 0001070081
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $4.63B
- Round Lot: 100
- Outstanding Shares: 79.44M
- Asset Type: CS
RECENT FILINGS FOR PTCT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 4 | View |
| 2025-09-09 | 144 | View |
| 2025-09-08 | 144 | View |
| 2025-09-02 | 4 | View |
| 2025-08-28 | 144 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 8-K | View |
| 2025-08-15 | 144 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-08-07 | 8-K | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 144 | View |
| 2025-07-28 | 8-K | View |
| 2025-07-17 | 4 | View |
| 2025-07-15 | 144 | View |
| 2025-06-17 | 8-K | View |
| 2025-05-19 | 4 | View |
| 2025-05-16 | 144 | View |
Latest News on PTCT